Unknown

Dataset Information

0

A point mutation in the extracellular domain of KIT promotes tumorigenesis of mast cells via ligand-independent auto-dimerization.


ABSTRACT: Mutations in the juxtamembrane and tyrosine kinase domains of the KIT receptor have been implicated in several cancers and are known to promote tumorigenesis. However, the pathophysiological manifestations of mutations in the extracellular domain remain unknown. In this study, we examined the impact of a mutation in the extracellular domain of KIT on mast cell tumorigenesis. A KIT mutant with an Asn508Ile variation (N508I) in the extracellular domain derived from a canine mast cell tumor was introduced into IC-2 cells. The IC-2(N508I) cells proliferated in a cytokine-independent manner and showed KIT auto-phosphorylation. Subcutaneous injection of IC-2(N508I) cells into the dorsal area of immunodeficient BALB/c-nu/nu mice resulted in the formation of solid tumors, but tumor progression was abrogated by treatment with a tyrosine kinase inhibitor (STI571). In addition, the N508I mutant KIT protein dimerized in the absence of the natural ligand, stem cell factor. Structure modeling indicates that the increased hydrophobicity of the mutant led to the stabilization of KIT dimers. These results suggest that this extracellular domain mutation confers a ligand-independent tumorigenic phenotype to mast cells by KIT auto-dimerization that is STI571-sensitive. This is the first report demonstrating the tumorigenic potential of a mutation in the extracellular domain of KIT.

SUBMITTER: Amagai Y 

PROVIDER: S-EPMC4428273 | biostudies-literature | 2015

REPOSITORIES: biostudies-literature

altmetric image

Publications

A point mutation in the extracellular domain of KIT promotes tumorigenesis of mast cells via ligand-independent auto-dimerization.

Amagai Yosuke Y   Matsuda Akira A   Jung Kyungsook K   Oida Kumiko K   Jang Hyosun H   Ishizaka Saori S   Matsuda Hiroshi H   Tanaka Akane A  

Scientific reports 20150512


Mutations in the juxtamembrane and tyrosine kinase domains of the KIT receptor have been implicated in several cancers and are known to promote tumorigenesis. However, the pathophysiological manifestations of mutations in the extracellular domain remain unknown. In this study, we examined the impact of a mutation in the extracellular domain of KIT on mast cell tumorigenesis. A KIT mutant with an Asn508Ile variation (N508I) in the extracellular domain derived from a canine mast cell tumor was int  ...[more]

Similar Datasets

| S-EPMC8562337 | biostudies-literature
| S-EPMC3039292 | biostudies-literature
| S-EPMC4522520 | biostudies-literature
| S-EPMC4234187 | biostudies-literature
| S-EPMC6123530 | biostudies-literature
| S-EPMC6233074 | biostudies-literature
| S-EPMC5026483 | biostudies-literature
| S-EPMC4125511 | biostudies-other
| S-EPMC7029481 | biostudies-literature
| S-EPMC2680999 | biostudies-literature